Spoken Alpha
VYNE
Yarrow Bioscience, Inc.
Overview
Yarrow Bioscience, Inc is a Healthcare company operating in Biotechnology with a $19.1M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 12, 2026).
3 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-07-26.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q2 FY20262026-08-12EPS— vs ——Rev$570.0K vs ——EODHD
- Q1 FY20262026-05-17EPS$-0.08 vs ——Rev$86.0K vs ——EODHD
- Q4 FY20252026-02-26EPS$-5.50 vs $-11.50+52.2%Rev$130.0K vs ——EODHD
- Q3 FY20252025-11-05EPS$-8.50 vs $-6.50-30.8%Rev$169.0K vs ——EODHD
- Q2 FY20252025-08-13EPS$-6.50 vs $-11.17+41.8%Rev$69.0K vs ——EODHD
- Q1 FY20252025-05-07EPS$-10.00 vs $-14.50+31.0%Rev$202.0K vs ——EODHD
- Q4 FY20242025-02-25EPS$-0.28 vs $-0.30+7.0%Rev$84.0K vs ——EODHD
- Q3 FY20242024-11-06EPS$-14.50 vs $-11.75-23.4%Rev$121.0K vs ——EODHD
- Q2 FY20242024-08-13EPS$-11.00 vs $-9.50-15.8%Rev$198.0K vs ——EODHD
- Q1 FY20242024-05-08EPS$-0.15 vs $-0.24+37.5%Rev$98.0K vs ——EODHD
- Q4 FY20232024-02-28EPS$-10.00 vs $-25.00+60.0%Rev$76.0K vs ——EODHD
- Q3 FY20232023-11-12EPS$-100.50 vs $-38.00-100.0%Rev$114.0K vs ——EODHD
- Q2 FY20232023-08-13EPS$-154.50 vs $-129.00-19.8%Rev$135.0K vs ——EODHD
- Q1 FY20232023-05-10EPS$-87.00 vs $-130.50+33.3%Rev$99.0K vs ——EODHD
- Q4 FY20222023-03-08EPS$-3.33 vs $-3.24-2.8%Rev$6.0K vs ——EODHD
- Q3 FY20222022-11-09EPS$-126.00 vs $-180.00+30.0%Rev$167.0K vs ——EODHD
- Q2 FY20222022-08-11EPS$-117.00 vs $-135.00+13.3%Rev$126.0K vs ——EODHD
- Q1 FY20222022-05-11EPS$-2.52 vs $-2.97+15.2%Rev$178.0K vs ——EODHD
- Q4 FY20212022-03-16EPS$-180.00 vs $-231.00+22.1%Rev$2.3M vs ——EODHD
- Q3 FY20212021-11-09EPS$-324.00 vs $-290.25-11.6%Rev$133.0K vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-12 | — | — | — | $570.0K | — | — | EODHD |
| Q1 FY2026 | 2026-05-17 | $-0.08 | — | — | $86.0K | — | — | EODHD |
| Q4 FY2025 | 2026-02-26 | $-5.50 | $-11.50 | +52.2% | $130.0K | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $-8.50 | $-6.50 | -30.8% | $169.0K | — | — | EODHD |
| Q2 FY2025 | 2025-08-13 | $-6.50 | $-11.17 | +41.8% | $69.0K | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $-10.00 | $-14.50 | +31.0% | $202.0K | — | — | EODHD |
| Q4 FY2024 | 2025-02-25 | $-0.28 | $-0.30 | +7.0% | $84.0K | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-14.50 | $-11.75 | -23.4% | $121.0K | — | — | EODHD |
| Q2 FY2024 | 2024-08-13 | $-11.00 | $-9.50 | -15.8% | $198.0K | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.15 | $-0.24 | +37.5% | $98.0K | — | — | EODHD |
| Q4 FY2023 | 2024-02-28 | $-10.00 | $-25.00 | +60.0% | $76.0K | — | — | EODHD |
| Q3 FY2023 | 2023-11-12 | $-100.50 | $-38.00 | -100.0% | $114.0K | — | — | EODHD |
| Q2 FY2023 | 2023-08-13 | $-154.50 | $-129.00 | -19.8% | $135.0K | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-87.00 | $-130.50 | +33.3% | $99.0K | — | — | EODHD |
| Q4 FY2022 | 2023-03-08 | $-3.33 | $-3.24 | -2.8% | $6.0K | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-126.00 | $-180.00 | +30.0% | $167.0K | — | — | EODHD |
| Q2 FY2022 | 2022-08-11 | $-117.00 | $-135.00 | +13.3% | $126.0K | — | — | EODHD |
| Q1 FY2022 | 2022-05-11 | $-2.52 | $-2.97 | +15.2% | $178.0K | — | — | EODHD |
| Q4 FY2021 | 2022-03-16 | $-180.00 | $-231.00 | +22.1% | $2.3M | — | — | EODHD |
| Q3 FY2021 | 2021-11-09 | $-324.00 | $-290.25 | -11.6% | $133.0K | — | — | EODHD |
Source: EODHD. VYNE reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for VYNE.
$ curl https://api.spokenalpha.com/v1/companies/VYNEFAQ
Frequently asked about VYNE
Where can I find Yarrow Bioscience, Inc.'s (VYNE) earnings call transcripts?
Spoken Alpha indexes VYNE's earnings call transcripts at https://spokenalpha.com/companies/VYNE. Each call links to attributed speakers and parsed analyst Q&A. Yarrow Bioscience, Inc.'s own investor relations page is at https://vynetherapeutics.com/investors-media/investor-overview/.
When was Yarrow Bioscience, Inc.'s most recent earnings call?
Yarrow Bioscience, Inc. (VYNE) held its most recent earnings call on 2021-11-10, covering fiscal Q3 2021.
What sector is VYNE in?
Yarrow Bioscience, Inc. (VYNE) operates in the Healthcare sector (Biotechnology industry).